MyReceptivaTM is the only test that can detect endometriosis and provide answers for unexplained pain and infertility.

Patient Advocate Tara Lipinsky

Olympic Figure Skater and Broadcaster

Endometriosis is a silent epidemic and women need to be their own advocates to push for earlier detection. My personal journey with endometriosis could have been so different if detected sooner. The MyReceptivaTM test gives answers and a clearer picture of the next steps to get the help you need.

Tara Lipinsky

Stay Informed with MyReceptiva

Get the latest updates and stay informed with MyReceptiva.

What is Endometriosis?

Endometriosis is a complex disease in which tissue that is similar to the endometrial lining of the uterus grows outside of the uterus. It typically grows on the ovaries, ovarian tubes, the outer wall of the uterus, the intestines, other organs in the abdomen and in some cases outside the abdomen. Pelvic pain and infertility are two of the hallmark symptoms of Endometriosis.

Currently, there is no known cause Or Cure For endometriosis.

Undiagnosed Endometriosis is a Global Problem.

  • The average time to an endometriosis diagnosis is 7 to 10 years.
  • 65% of women with endometriosis are misdiagnosed with 46% having to see more than 5 doctors before getting an accurate diagnosis.

  • Endometriosis affects approximately 10% of women of reproductive age globally.
  • Endometriosis is the primary cause of 30 to 50% of infertility in women.
  • Endometriosis is the primary cause of 70 to 90% of pelvic pain in women.
  • Endometriosis is the second leading cause of hysterectomies in the U.S.

What is the MyReceptivaTM Test?

MyReceptivaTM identifies inflammation on the uterine lining using a protein marker, BCL6, that if present, is highly associated with endometriosis.*

MyReceptivaTM was created to help women determine if endometriosis is the cause of their pelvic pain or the reason for their infertility or recurrent pregnancy loss. Offered  through IVF centers for the last 7 years, this test is now available directly to women accessing their Ob-Gyn or Women’s Healthcare provider.

* The MyReceptivaTM test is based on a timed endometrial biopsy sample collected by your Women’s Healthcare specialist.

Learn more about the test

Who Should Consider The MyReceptivaTM Test?

Endometriosis symptoms are frequently non-specific, making diagnosis difficult.

Endometriosis Symptoms

  • Undiagnosed pelvic or abdominal pain.
  • Family history of endometriosis, pelvic or abdominal pain.
  • Pain during and after sex.
  • Recurrent bladder or bowel pain.
  • High Body Mass Index (BMI) combined with non-specific symptoms such as anxiety, depression or fatigue.

  • For additional common symptoms, visit icarebetter.com.

Infertility Issues

  • Women 34 and under who have failed to conceive after 12 months of trying to conceive naturally.

  • Women 35 and over with unexplained infertility after 6 months of trying to conceive naturally.
  • Women with one or more consecutive miscarriages during the first 13 weeks of pregnancy.
  • Women and families wanting to screen before considering expensive next steps such as IVF.

Early diagnosis and treatment can mitigate later complications.

Trusted by Experts.

The only test used by over 75% of IVF Fertility doctors to detect endometriosis and confirmed by gynecologic surgeons specializing in laparoscopy.

OB/GYN and fertility specialist Dr. Aimee Eyvazzadeh. Dr. Aimee is a Caucasian woman with long dark hair wearing a blue cap-sleeve dress with a v-neck.

Dr. Aimee Eyvazzadeh, MD

OB/GYN, Fertility Specialist

The MyReceptiva™ test is an important advancement for women with fertility issues. The results can be life-changing, even for women not currently considering IVF. I’ve been using BCL6 analysis since 2017 and have helped thousands of women use those results to move forward and start a family.

Dr. Aimee
Learn About Dr. Aimee

Dr. Mona Orady, MD

FACOG Gynecologic Surgeon

For years, the women’s healthcare field has lacked a test that could assist in triaging patients with undiagnosed pelvic or abdominal pain. The MyReceptivaTM test has proven to be a powerful predictor of endometriosis that can be performed during a routine office visit allowing for expedited referrals to endometriosis specialists for an official diagnosis and a proper treatment plan.

Dr. Orady
Learn About Dr. Orady

MyReceptivaTM Endometriosis Detection.

The MyReceptivaTM test is highly accurate for detecting uterine inflammation associated with endometriosis and has been independently verified by multiple laparoscopy centers.

MyReceptiva test sensitivity is 93% while test specificity is 96%.

Sensitivity

93 out of 100 endometriosis cases will be detected. Just 7% of cases will go undetected.

Specificity

Highly accurate for uterine inflammation, but in 4% of cases endometriosis will not be the source of inflammation.

Testing with Confidence.

  • Over 35,000 women tested.
  • 25 peer-reviewed publications demonstrating clinical utility and successful outcomes.
  • Trusted by over 450 fertility centers globally and now available and affordable for all patients with undiagnosed pain or unexplained infertility.

Take the first step to getting the answers you need with MyReceptivaTM

Take charge of your health.

  • The facts are clear. Endometriosis is missed or overlooked by many physicians.
  • Almost half of women saw 3 to 5 providers before being diagnosed.
  • This is your body and your choice.

  • Asking for the test with a kit in your hands and the facts to support you ensures your doctor will listen to your concerns.

Order Your Collection Kit

1 in 10 American women will be afflicted with Endometriosis, which is why we’re determined to provide answers and solutions. Millions of women have suffered from endometriosis and have been able to find solutions.

We are here to help.